All research
Liraglutide 2018-01-31 ClinicalTrials

Liraglutide + OPTIFAST regimen hypothesized to medically reproduce bariatric surgery for Type 2 diabetes remission

Medically Reproducing Bariatric Surgery

Abstract

Liraglutide and OPTIFAST are hypothesized to medically reproduce bariatric surgery's Type 2 diabetes remission effects, reducing medication intensity.


Source: clinicaltrials:NCT03225209 · Ingested 2026-06-01 · Digest: gemini-2.5-flash